Posted By J. Garcia / Sin categoría / No hay comentarios

Molecular diagnostics have improved the diagnosis and treatment of millions of patients worldwide allowing clinicians to diagnose patients earlier as well as providing better ongoing therapies.


At microLIQUID we develop fully automated sample preparation and molecular diagnostic systems based on microfluidics.


Non-microfluidic diagnostic instruments usually require an important quantity of costly reagents, long analysis time, established lab infrastructure and trained professionals to operate, which limits their availability for large-scale screening applications in developed countries and primary care in developing countries. There is a strong demand for robust, cost-effective, and simple-to-operate instruments for molecular diagnostics.


Microfluidics systems have many advantages, such as short analysis time, reduction in fabrication costs, and low sample/reagent consumption.


Besides, most current microfluidic diagnostic devices are designed to target a single disease, such as a given cancer or a variety of pathogens. The future of molecular diagnostics lies in highly multiplexed microfluidic devices that can screen for potentially hundreds of diseases simultaneously.


microLIQUID is committed with the development of diagnostic systems, having the experience and expertise to develop and manufacture fully automated sample preparation and molecular diagnostics systems.

Leave a Comment


where are we?